TP53 and breast cancer: To experimentally probe the effect of microRNA abrogation on the p53-MDM2 oscillator we used a breast cancer cell line MCF7 [38] that contains a stably integrated fluorescent reporter Venus fused to the cDNA of p53 under the expression of the metallothionein promoter (Fig 5a).